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The carboxy-termini of classical cadherins and
desmocollins have been shown to play an important
role in initiating desmosome assembly. In this study
we wanted to determine whether the carboxy-
terminal cytoplasmic domains of desmoglein 3 are
important for targeting it to the desmosome. By
generating stably transfected A431 cell lines with
chimeric constructs encoding for the extracellular
domain of E-cadherin and the transmembrane and
intracellular region of human desmoglein 3, we
could show that the cytoplasmic tail is suf®cient to
target the protein to the desmosome. By generating
truncations of the carboxy-terminus we investigated
the importance of the various intracellular sub-
domains. Whereas the construct encoding the
intracellular cadherin-type segment domain still
allowed its incorporation into the desmosome,
further truncation, leaving only the intracellular
anchor domain, did not. Deletion of the 87 amino
acid long plakoglobin-binding site within the intra-
cellular cadherin-type segment domain demonstrated
that this region is essential for targeting desmoglein
3 to the desmosome. Absent the plakoglobin-binding
site the chimeric molecule colocalizes with b-catenin
rather than desmoplakin. We conclude that binding
of plakoglobin to desmoglein 3 is an important step
in desmosome assembly and leads to the incor-
poration of desmoglein 3 into the desmosome.
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T
he desmosome, an intercellular adhesion complex, is
composed of two major transmembrane proteins,
desmogleins (Dsg) and desmocollins, as well as several
cytoplasmic proteins, including desmoplakins and
plakoglobin, and plays an important role in establish-
ing tissue integrity (reviewed by Koch and Franke, 1994; Garrod et
al, 1996; Kowalczyk et al, 1999). Two hypotheses relating to how
desmosomes are assembled have been proposed. One suggests that
desmosomal components preassemble to half-desmosomes on the
cell surface, and then build complete desmosomes with neighbor-
ing cells (Dehmlehner et al, 1995). The other model proposes that
the different components are only initiated to form desmosomes or
stabilized in an insoluble pool, presumably desmosomes, by prior
cell±cell contact induced, for example, by classical cadherins (Pasdar
and Nelson, 1989; Pasdar et al, 1991; Lewis et al, 1994, 1997).
Several studies have supported a central role of the adherens
junction in desmosome assembly. In cultured keratinocytes anti-
bodies against E-cadherin (Ecad) and P-cadherin are able to prevent
desmosome assembly, presumably by interfering with the assembly
of adherens junctions (Lewis et al, 1994). Another study on cultured
keratinocytes demonstrated that the expression of a dominant
negative N-cadherin prevented desmosome assembly, again pre-
sumably through its inhibition of normal adherens junction
assembly (Amagai et al, 1995). Furthermore, desmosome formation
has been shown to be initiated by prior assembly of adherens
junctions (Lewis et al, 1997).
Additional studies have suggested that plakoglobin, a component
common to both adherens junctions and desmosomes (Cowin et al,
1986), is a critical link between adherens junction and desmosome
assembly. In a subclone of A431 cells that expresses no classical
cadherins and only minimal amounts of plakoglobin, transfection of
Ecad allowed adherens junction but not desmosome formation.
Further addition of plakoglobin, however, allowed desmosome
formation by clustering desmosomal components that were
diffusely spread on the plasma membrane before transfection
(Lewis et al, 1997). The role of plakoglobin in clustering
desmosomal components is also substantiated by data showing
that it affects the size of desmosomes (Palka and Green, 1997).
These data suggest that plakoglobin is not only a structural
component, but also is central to the regulation of desmosome
formation in association with classical cadherins.
Plakoglobin may contribute to desmosome assembly through its
interaction with desmocollins. The cytoplasmic domain of
desmocollins of the ``a'' splice form, coding for an isoform with a
longer cytoplasmic tail that is able to bind plakoglobin, has been
shown to nucleate desmosome formation, whereas desmocollins of
the shorter ``b'' splice form cannot associate with plakoglobin and
do not have the ability to nucleate desmosome formation
(Troyanovsky et al, 1993, 1994a). Recent studies suggest this
nucleation may occur through desmocollin binding to b-catenin in
adherens junctions. Subsequently, desmocollin, once localized to
the cell surface at adherens junctions, can in turn bind plakoglobin
initiating further assembly of the desmosome (Hanakawa et al,
2000). After these initial steps, desmoplakin may cluster the
desmosome through binding of plakoglobin (Kowalczyk et al,
1997).
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The above data suggest that the cytoplasmic domains of Dsg and
desmocollins are critical elements in desmosome assembly. Other
evidence, however, suggests that the extracellular domains may also
play a role in clustering the components of adherens junctions and
desmosomes. Crystallographic studies show that the extracellular
domains of classical cadherins form a zipper-like trans-interaction
(Shapiro et al, 1995). Other studies suggest that the extracellular
domains may play an important role in clustering not only of
classical cadherins, but also of desmosomal cadherins (Hanakawa et
al, 2000). For example, the cadherin-like repeat in the extracellular
domain of desmocollin 1a has been shown to bind directly to the
extracellular domain of Dsg2 to form lateral clusters (Chitaev and
Troyanovsky, 1997).
To further elucidate the elements involved in desmosome
assembly we studied the incorporation of Dsg3 into desmosomes.
We chose to study Dsg3 rather than Dsg1 because the cytoplasmic
domain of Dsg1 often acts as a dominant-negative mutant
(Troyanovsky et al, 1993; Norvell and Green, 1998), perhaps
because of its ability to bind large amounts of plakoglobin and
thereby compete for limited endogenous plakoglobin, a mechanism
similar to that suggested for the dominant-negative effects of N-
cadherin through competition for b-catenin (Kintner, 1992).
We generated a chimeric construct containing the extracellular
domain of Ecad and the transmembrane and intracellular domain of
human Dsg3 to address the following questions. Is the extracellular
domain needed for incorporation of Dsg3 into the desmosome?
Second, is the cytoplasmic tail of Dsg3 suf®cient to target it to the
desmosome? We generated cDNA constructs encoding deletions of
the cytoplasmic domain to determine which subdomains of Dsg3
are suf®cient for its incorporation into desmosomes. The constructs
were used to transfect A431 cells that feature extensive desmo-
somes. Considering the above data suggesting that plakoglobin has
a central role in desmosome assembly we tested the speci®c
hypothesis whether the plakoglobin-binding domain in Dsg3 is
important for desmosome incorporation.
MATERIALS AND METHODS
Expression vectors and cloning A chimeric construct containing
the extracellular domain of mouse Ecad, the transmembrane and
intracellular domains of human Dsg3, and a c-myc epitope-tag with the
amino acid sequence EQKLISEEDLN (single letter amino acid code)
was generated in pcDNA3.1 (Invitrogen, Carlsbad, CA) (Fig 1a). The
mammalian expression vector LK 444, which uses a b-actin promoter,
kindly provided by Dr. Kathleen Green (Kowalczyk et al, 1994), was
digested with BamHI and the 5¢ overhangs were converted into blunt
ends by using T4 DNA polymerase (DNA blunting kit, Takara, Panvera,
Madison, WI). For construction of the 3¢ end deletion mutants the full-
length chimeric construct encoding EcadDsg3myc in pcDNA3.1 was
digested with EcoRV and XbaI and ®rst subcloned into the
corresponding restriction enzyme sites in pBluescript SK II+ (Stratagene,
La Jolla, CA). Polymerase chain reaction (PCR) was used to generate
various deletion mutants by using 3¢ primers complementary to
sequences upstream from the 3¢ end of cDNA encoding EcadDsg3 and a
sequence encoding the myc epitope-tag and an XbaI site was added to
the 3¢ end of these primers (PCR Supermix High Fidelity, Gibco,
Gaithersburg, MD). The 5¢ primer was upstream of a unique NdeI
restriction site in the cDNA encoding the extracellular domain of Ecad.
PCR products were digested with NdeI and XbaI for subcloning into
the corresponding sites in the EcadDsg3myc cDNA. Final products of
the sequential deletions are shown in Fig 1(a). The different constructs
in pBluescript were then digested with EcoRV and XbaI and the 5¢
overhangs were converted into blunt ends as described above for ligation
with LK 444.
cDNA encoding full-length Ecad was subcloned into the EcoRV
restriction site in the multiple cloning site of pBluescript SK II+. To add
a carboxy-terminal myc tag a 5¢ primer, upstream of a unique NheI site,
and a 3¢ primer, encoding the myc sequence and containing a HinDIII
restriction site, were chosen. Utilizing the HinDIII site in the multiple
cloning site of pBluescript the PCR fragment was digested with NheI
and HinDIII and subcloned into the corresponding sites of the vector.
The construct encoding Ecad and the carboxy-terminal myc epitope-tag
was then digested with NotI and HinDIII; the 5¢ overhangs were
converted into blunt ends and subcloned into LK 444 as described
above.
All constructs were veri®ed by DNA sequencing.
Stable transfection of A431 cells A431 cells were grown in 120 mm
dishes at 37°C overnight. Six microliters of FuGene 6 reagent (Roche,
Indianapolis, IN) were preincubated with 94 ml Dulbecco's modi®ed
essential medium (DMEM) for 5 min. Three micrograms of vector DNA
were diluted in 10 ml water and incubated with FuGene 6 medium for
15 min at room temperature following the manufacturer's instructions.
Cells were incubated with the FuGene 6±DMEM±DNA mixture for
Figure 1. Ecad±Dsg3 chimeric molecules, their expression in
transfected A431 cells, and their ability to bind plakoglobin. (a)
Diagram of Ecad±Dsg3 chimeric constructs. The full-length chimeric
construct encoding EcadDsg3myc contains all subdomains of the Dsg3
cytoplasmic tail, the IA, the ICS subdomain, the IPL, and RUD, a series
of 29 amino acid repeats. EcadDsg3ICSmyc is truncated at the carboxy-
terminus by 133 amino acids, and expresses the IA and ICS subdomains.
EcadDsgDICSmyc has another 87 amino acids deleted from the carboxy-
terminus of the ICS subdomain, which leaves a product lacking the part
of the ICS subdomain that is thought to bind plakoglobin. The shortest
fragment, EcadDsg3IAmyc, expresses the IA domain only. EC,
extracellular domain, TM, transmembrane domain, IC, intracellular
domain, Pg, plakoglobin, DP, desmoplakin, aa, amino acids. (b)
Immunoblotting with anti-Ecad of extracts from stably transfected A431
cells. Transfected products were detected at predicted molecular weights.
(c) Immunoblots of immunoprecipitates of chimeric proteins to
determine their ability to bind plakoglobin. Immunoprecipitation of
A431 stably transfected cells in lanes a were with rabbit antimyc
antibodies, and in lanes b with normal rabbit serum. Immunoblots with
antimouse Ecad detected the chimeric protein and with antiplakoglobin
(Pg) detected whether plakoglobin was coprecipitated. Lane 1, Ecadmyc;
lane 2, EcadDsg3myc; lane 3, EcadDsg3ICSmyc; lane 4,
EcadDsg3DICSmyc; lane 5, EcadDsg3IAmyc. Ecadmyc, EcadDsg3myc,
and EcadDsg3ICSmyc, but not the other chimeric molecules,
coprecipitate plakoglobin.
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48 h and then transferred into DMEM containing 10% fetal bovine
serum and 900 mg per ml G418 (Mediatech, Herndon, VA) for selection.
Immunostaining of stable cell lines Stably transfected A431 cells
were grown overnight at 37°C in two-well chamber slides (Nalge Nunc,
Naperville, IL). After 8 min ®xation in 1:1 methanol:acetone cells were
treated with 10% Triton X-100 (Sigma, St. Louis, MO) in phosphate-
buffered saline without magnesium and calcium (PBS) for 3 min. Cells
were washed with PBS and blocked with 1% bovine serum albumin
(Sigma) for 1 h. Incubation with the following primary antibodies was
for 1 h at room temperature: rabbit antidesmoplakin (Serotec, Raleigh,
NC), mouse antimyc 9E10 (Cell Center, University of Pennsylvania,
PA), rabbit antimyc antibody (raised against the c-myc epitope-tag
EQKLISEEDL linked to KLH), mouse anti-b-catenin (Transduction
Laboratories, Lexington, KY) and mouse antiplakoglobin 15F11 (Sigma).
After washing with PBS, cells were incubated with ¯uorescein
isothiocyanate (FITC) conjugated and Texas-Red-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratory, West Grove, PA) for
1 h. Confocal images were taken with the Leica TCS 4D (Leica,
Heidelberg, Germany) at a magni®cation of 1003.
Immunoblotting Stably transfected cell lines were grown to
con¯uence in six-well plates (Falcon, Bridgeport, NJ) at 37°C. They
were harvested for immunoblotting by adding 200 ml 2 3 Laemmli
sample buffer (Bio-Rad, Hercules, CA) and boiled for 10 min. Samples
were analyzed for their protein content using the Bio-Rad Protein Assay
before electrophoresis on 6% Tris-glycine gels (NOVEX, Invitrogen).
Proteins were transferred to Trans-Blot Transfer Medium nitrocellulose
membrane (Bio-Rad) for 2 h at 40 V. After blocking in 1% Carnation
milk for 1 h, the membrane was incubated with mouse antimyc 9E10
antibody 1:1000, rat antimouse Ecad ECCD-2 1:50, mouse antihuman
Ecad HECD-1 1:500 (kind gifts from Dr. M. Takeichi), mouse
antiplakoglobin 15F11 1:500 (Sigma), rabbit antidesmoplakin 1:100
(Serotec, Raleigh, NC), or mouse DG3.10, recognizing Dsg1 and Dsg2,
1:100 (Biodesign, Kennebunk, ME), mouse anti-b-catenin 1:100
(Transduction Laboratories), for 1 h, washed three times for 5 min each
in PBS containing 0.5% Tween 20, and incubated with horseradish-
peroxidase-conjugated goat antimouse IgG (Bio-Rad), horseradish-
peroxidase-conjugated goat antirabbit IgG (Bio-Rad), or horseradish-
peroxidase-conjugated goat antirat IgG (Boehringer Mannheim, Roche,
Indianapolis, IN) antibodies. The ECL system was used as substrate with
Hyper®lm for detection (Amersham Pharmacia, Uppsala, Sweden).
Immunoblotting was also performed on immunoprecipitates.
Immunoprecipitation of extracts of stably transfected A431
cells Pre-con¯uent cells in T-25 ¯asks (Falcon, Bridgeport, NJ) were
washed with PBS and incubated with 700 ml lysis buffer [1% Triton X-
100, 1% Nonidet P-40, 150 mM NaCl, 50 mM Tris, pH 8, and
proteinase inhibitors: 100 mg per ml phenylmethylsulfonyl ¯uoride, 2 mg
per ml leupeptin (Sigma); 2 mg per ml aprotinin (Roche)] for 30 min on
ice. Seventy microliters of 4% bovine serum albumin and 140 ml 1.5 M
NaCl were added to the extract, which was then preabsorbed with 10 ml
rProteinG agarose (Gibco) for 1 h at 4°C. Preabsorbed extracts were
divided into two samples, one for incubation with normal rabbit serum
as control and one for incubation with rabbit antimyc antibody (raised
against the c-myc epitope-tag EQKLISEEDL linked to KLH). After 1 h
incubation at 4°C the antigen±antibody complex was incubated with
10 ml rProteinG agarose for 1 h at 4°C. The precipitates were washed
three times with 1 ml wash buffer (50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% sodium dodecyl
sulfate) and boiled with 100 ml 2 3 Laemmli sample buffer (Bio-Rad)
for 10 min. Supernatants were used for immunoblotting as described
above.
RESULTS
The extracellular domain of Dsg3 is not necessary for
desmosome incorporation To evaluate the importance of the
cytoplasmic tail of Dsg3 for targeting it to the desmosome we
constructed a cDNA encoding from 5¢ to 3¢ the extracellular
domain of mouse Ecad, the transmembrane and intracellular
domains of human Dsg3, and the c-myc epitope-tag. This
construct encoded a chimeric protein called EcadDsg3myc
(Fig 1a). Expression vectors containing the cDNA construct
encoding this chimeric protein were used to stably transfect A431
cells. The transfected cells were then subjected to double-staining
immuno¯uorescence with antimyc antibodies detected with Texas-
Red-conjugated secondary antibody to localize the chimeric
protein and antidesmoplakin antibody detected with FITC-
conjugated secondary antibody to localize the desmosome.
Confocal microscopy showed colocalization, demonstrating that
the transmembrane and cytoplasmic domains are suf®cient for
localization of Dsg3 to the desmosome, and that the extracellular
domain of Dsg3 is not necessary (Fig 2). As controls, A431 cells
were stably transfected with cDNA encoding full-length Ecad with
a carboxy-terminal myc tag (Ecadmyc). Confocal microscopy of
these cells with antimyc and antidesmoplakin antibodies does not
show colocalization and demonstrates that this technique clearly
distinguishes cell surface proteins that localize to desmosomes from
those that do not (Fig 6b).
The plakoglobin-binding domain of Dsg3 is necessary for
desmosome incorporation To study which domains of the
cytoplasmic tail of Dsg3 are necessary to target the protein to the
desmosome we used constructs encoding the extracellular domain
of Ecad and the transmembrane and cytoplasmic domains of Dsg3
with sequential truncations of the carboxy-terminus, all cDNAs
encoding a c-myc epitope-tag at the 3¢ end (Fig 1a). These
constructs were used for stable transfections of A431 cells. Ecadmyc
was used as an additional control.
The full-length chimeric construct EcadDsg3myc contains all
subdomains of the cytoplasmic tail, the intracellular anchor (IA),
Figure 2. Colocalization of EcadDsg3myc and desmoplakin. Double-staining immuno¯uorescence of A431 cells expressing EcadDsg3myc. The
antidesmoplakin antibody (a) detected with FITC-conjugated secondary antibody localizes the desmosome, and the antimyc antibody (b) detected with
Texas-Red-conjugated secondary antibody localizes the chimeric protein. Confocal microscopy shows colocalization (c), demonstrating the integration
of the chimeric protein into the desmosome. Scale bar: 10 mm.
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the intracellular cadherin-type segment (ICS) subdomain, intra-
cellular proline-rich linker (IPL), and the repeated unit subdomains
(RUD), a series of 29 amino acid repeats (for subdomain
nomenclature see Fig 1 in Buxton and Magee, 1992).
EcadDsg3ICSmyc is truncated at the carboxy-terminus by 133
amino acids, and contains only the IA and the ICS subdomains.
EcadDsg3DICSmyc has another 87 amino acids deleted from the
carboxy-terminus of the ICS subdomain, which leaves a product
lacking the part of the ICS subdomain that is thought to bind
plakoglobin. The shortest fragment we generated,
EcadDsg3IAmyc, expresses the IA domain only.
Extracts of stably transfected A431 cells were used to con®rm the
correct size of the expressed proteins by immunoblotting (Fig 1b)
and immunoblots of antimyc immunoprecipitations were per-
formed to examine their association with plakoglobin (Fig 1c).
Ecadmyc immunoprecipitated with antimyc antibody and immu-
noblotted with antiplakoglobin antibody shows coimmunopreci-
pitation of plakoglobin (Fig 1c, lane 1a). Immunoblotting of
precipitated EcadDsg3myc with anti-Ecad antibody indicates a
band of approximately 150 kDa (Fig 1c, lane 2a, upper panel).
Immunoblotting with antiplakoglobin antibody of the precipitated
EcadDsg3myc shows coprecipitated plakoglobin (Fig 1c, lane 2a,
lower panel). The deletion of the intracellular subdomains IPL and
RUD leads to a truncated protein, EcadDsg3ICSmyc, that is
detected by anti-Ecad antibodies on immunoblots as a band of
approximately 130 kDa (Fig 1b, lane 3). This product also
coprecipitates plakoglobin (Fig 1c, lane 3a). Finally, deletion of
only 87 amino acids from the carboxy-terminus of the ICS
(EcadDsg3DICSmyc) and deletion of the complete ICS subdomain
(EcadDsg3IAmyc) result in products on immunoblots of the
expected sizes (120 and 110 kDa, respectively, Fig 1b, lanes 4, 5),
but these products do not coprecipitate plakoglobin (Fig 1c, lanes
4a, 5a, lower panel).
To determine if expression of these chimeric constructs caused
major perturbations of other desmosomal or adherens junction
components, we performed immunoblotting of extracts from the
stably transfected A431 clones for various junctional molecules
(Fig 3). No major changes in expression were detected.
A431 cells stably transfected with expression vectors encoding
EcadDsg3myc with sequential truncations of the Dsg3 cytoplasmic
domain were stained with antimyc (detected with Texas Red) and
antidesmoplakin (detected with FITC) antibodies, as described
above, and analyzed by confocal microscopy to determine local-
ization of the various truncated chimeric proteins to desmosomes.
Although EcadDsg3ICSmyc is lacking the IPL and RUD domains
of the Dsg3 intracellular domain, it is still colocalized with
desmoplakin at the sites of desmosomes (Fig 4a).
To further test our hypothesis that the plakoglobin-binding
domain is important for integration of Dsg3 into the desmosome,
we analyzed A431 cells transfected with the construct for
EcadDsg3DICSmyc, which is lacking the carboxy-terminal 87
amino acids of the ICS subdomain and no longer binds
plakoglobin. Confocal microscopy of these cells demonstrated
membrane staining. Although EcadDsg3DICSmyc localizes at the
membrane, it does not integrate into the desmosome (Fig 4b).
Further truncation of the cytoplasmic domain to
EcadDsg3IAmyc results in a protein that is expressed with mainly
a cytoplasmic localization, as determined by confocal microscopy
(Fig 4c). The reason for this type staining is not clear, but to
exclude the possibility that the cytoplasmic localization is simply
due to an overexpression of the transfected construct, we
performed immunoblots with antimyc antibodies of different cell
lines expressing EcadDsg3IAmyc compared to EcadDsg3ICSmyc
and EcadDsg3DICSmyc, which do localize to the membrane
(Fig 5). The results show that the expression level for most
EcadDsg3IAmyc clones was comparable (clones 1, 4, 5) or even
lower (clones 2, 3, 6, 7) than that of EcadDsg3ICSmyc. Thus, the
cytoplasmic localization of EcadDsg3IAmyc does not appear to
correlate to the protein expression level.
Without the plakoglobin-binding domain EcadDsg3D-
ICSmyc colocalizes with adherens junctions To determine
if EcadDsg3DICSmyc incorporates into adherens junctions rather
than desmosomes, we performed double immuno¯uorescence of
A431 cells expressing EcadDsg3DICSmyc stained with antimyc
antibody (Texas-Red-conjugated secondary antibody) and anti-b-
catenin antibody (FITC-conjugated secondary antibody). Controls
of A431 cells expressing Ecadmyc showed colocalization with b-
catenin (Fig 6a±a¢¢), clearly distinct from staining with
antidesmoplakin (Fig 6b). With the loss of the 87 amino acids
encoding for the plakoglobin-binding site EcadDsg3DICSmyc also
showed colocalization with b-catenin (Fig 6c) rather than
desmoplakin (Fig 4b), leading to the assumption that this
chimeric molecule localizes to adherens junctions rather than to
desmosomes.
Figure 3. Extracts of A431 cells expressing Ecadmyc and
EcadDsg3 chimeric proteins show no major perturbations in the
expression levels of various cell junction components.
Immunoblots of cell lysates of A431 cells expressing full-length Ecadmyc
and EcadDsg3myc, and its truncated derivatives, show no major changes
in expression of other cell junction components. DP, desmoplakin, Pg,
plakoglobin.
VOL. 117, NO. 5 NOVEMBER 2001 Dsg3 INCORPORATION INTO DESMOSOMES 1071
An explanation for colocalization of EcadDsg3DICSmyc with
adherens junctions could be that the truncated cytoplasmic domain
of Dsg3 binds b-catenin rather than plakoglobin. We tested this
hypothesis, but could detect no b-catenin binding (Fig 7).
DISCUSSION
To investigate the importance of the Dsg3 cytoplasmic domain, and
in particular its ability to bind plakoglobin, for integration into the
desmosome, we constructed a chimeric molecule encoding the
extracellular domain of mouse Ecad and the intracellular domain of
Dsg3. By transfecting A431 cells with EcadDsg3myc and with
constructs bearing sequential truncations of the cytoplasmic tail of
Dsg3 we could show that the intracellular domain alone could
direct integration of Dsg3 into the desmosome. Our result is in
contrast to previous studies using chimeric constructs with the Dsg1
intracellular domain, which had a dominant-negative effect on
desmosome formation (Troyanovsky et al, 1993; Norvell and
Green, 1998). Whereas full-length Dsg1 incorporated into or
disrupted endogenous desmosomes depending on its level of
expression, a chimera containing the extracellular domain of Ecad
and the intracellular domain of Dsg1 disrupted desmosome
assembly (Troyanovsky et al, 1993; Norvell and Green, 1998).
It was argued that this dominant-negative effect was due to the
fact that plakoglobin is bound in such a manner that the pool of
endogenous plakoglobin is too low to support formation of
desmosomes. Troyanovsky et al (1994b) described that the
dominant-negative effect can be abrogated by removal of the
plakoglobin-binding site. This supports the idea that the dominant-
negative effect may be caused by the high af®nity of Dsg1 for
plakoglobin that prevents suf®cient binding of plakoglobin to Ecad
and inhibits the initiation of desmosome formation through
adherens junctions. The fact that our construct containing the
intracellular domain of Dsg3 does not have a dominant-negative
effect might be due to a lower af®nity to plakoglobin compared to
the intracellular domain of Dsg1. Nevertheless, the observation that
removal of the plakoglobin-binding site in the Dsg1 chimera
abolished the dominant-negative effect underscores the importance
of plakoglobin binding for the assembly of the desmosome
(Troyanovsky et al, 1994b).
The ICS domain in desmosomal cadherins shows high sequence
identity. Comparison between the 87 amino acids responsible for
plakoglobin binding in Dsg3 with the sequences in Dsg1 and Dsg2
shows 66% and 48% identity, respectively. Considering conserva-
tive amino acid exchanges the percentage of homology rises to 83%
and 62%, respectively. (For comparison of the amino acid
sequences of the ICS domain in Dsg and Ecad see Roh and
Stanley, 1995, Fig 5).
Our observation that, absent plakoglobin binding,
EcadDsg3DICSmyc colocalizes with b-catenin rather than desmo-
plakin, yet does not bind strongly to b-catenin, suggests that the
extracellular domain of Ecad may localize the chimeric molecule
lacking the plakoglobin-binding domain to adherens junctions,
through lateral homophilic interactions. Further studies will be
needed, however, to address the mechanism of localization.
Our ®ndings indicate that plakoglobin binding plays an import-
ant role for Dsg3 incorporation into desmosomes. These results are
consistent with previous studies that implicate the adherens
junction as important for nucleation of desmosomes. Classical
Figure 4. Effect of truncation of Dsg3 cytoplasmic tail on incorporation into desmosomes. Confocal microscopy of double-staining
immuno¯uorescence for EcadDsg3ICSmyc (a), EcadDsg3DICSmyc (b), and EcadDsg3IAmyc (c)with antidesmoplakin antibody (FITC detected) and
antimyc antibody (Texas Red detected). Although EcadDsg3ICSmyc is lacking the IPL and RUD domains of the Dsg3 intracellular domain, it is still
colocalized with desmoplakin at the sites of desmosomes (a). EcadDsgDICSmyc localizes at the membrane, but it does not integrate into the
desmosome (b). In contrast, EcadDsg3IAmyc does not localize to the membrane, but instead shows a cytoplasmic staining pattern (c). Scale bar: 10 mm.
Figure 5. Expression levels for EcadDsg3IAmyc compared to
those of EcadDsg3ICSmyc and EcadDsg3DICSmyc in different
cell clones. Extracts of A431 cells stably transfected with
EcadDsg3ICSmyc, EcadDsg3DICSmyc, and EcadDsg3IAmyc were
subjected to immunoblotting using antimyc antibody to determine the
expression level in different clones. In the ®rst and second lanes control
extracts of EcadDsg3ICSmyc and EcadDsg3DICSmyc were analyzed to
show that EcadDsg3IAmyc clones 1±7 express comparable or lower
amounts of protein. The cytoplasmic localization of EcadDsg3IAmyc
does not correlate with the protein expression level.
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cadherins in these junctions can bind plakoglobin, which in turn
may recruit desmocollin and Dsg. Alternatively, desmocollins and
Dsg may also be recruited by binding to the b-catenin in these
junctions (Norvell and Green, 1998; Bierkamp et al, 1999), and
then, subsequently, recruit and bind plakoglobin. In any case, the
stronger binding of plakoglobin to the desmosomal cadherins,
compared to the classical cadherins, could presumably contribute to
the sorting and aggregation of these molecules into the desmosome.
Although the exact sequence of events in the assembly of
desmosomes remains to be determined, our studies and others
indicate that plakoglobin plays a central role.
This work was supported by a grant from the NIH.
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